Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania

International Journal of Infectious Diseases

Volumn 13, Issue 1, 2009, Pages 81-89

  Paraschiv, Simona ^a   Otelea, Dan ^a   Baicus, Cristian ^b   Tinischi, Mihaela ^a   Costache, Marieta ^c   Neaga, Emil ^a  

^a 'Prof Dr Matei Bals' National Institute for Infectious Diseases   (Romania)

^b V Babes National Institute of Pathology   (Romania)

^c UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

F1 subtype; HIV 1; NRTI resistance mutations

Indexed keywords

ABACAVIR; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE INSERTION; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; ROMANIA; UNINDEXED SEQUENCE; VIRUS ISOLATION; VIRUS STRAIN;

EID: 58049199394     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.03.032     Document Type: Article

References (19)

1. Palmer S., Shafer R.W., and Merigan T.C. Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development. AIDS 13 (1999) 661-667
2. Meyer P.R., Matsuura S.E., Mian A.M., So A.G., and Scott W.A. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol Cell 4 (1999) 35-43
3. Clavel F., and Hance A.J. HIV drug resistance. N Engl J Med 350 (2004) 1023-1035
4. Larder B.A., Bloor S., Kemp S.D., Hertogs K., Desmet R.L., Miller V., et al. A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. Antimicrob Agents Chemother 43 (1999) 1961-1967
5. Boyer P.L., Sarafianos S.G., Arnold E., and Hughes S.H. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J Virol 75 (2000) 4832-4842
6. Marcelin A.G., Delaugerre C., Wirden M., Viegas P., Simon A., Katlama C., et al. Thymidine analogue reverse transcriptase inhibitor resistance mutation profiles and association to other nucleoside reverse transcriptase inhibitor resistance mutations observed in the context of virological failure. J Med Virol 72 (2004) 162-165
7. Miller M.D. K65R, TAMs and tenofovir. AIDS Rev 6 (2004) 22-33
8. Apetrei C., Necula A., Holm-Hansen C., Lousert-Ajaka I., Pandrea I., Cozmei C., et al. HIV-1 diversity in Romania. AIDS 12 (1998) 1079-1085
9. Op de Coul E., Van der Burg R., Asjo B., Goudsmit J., Cupsa A., Pascu R., et al. Genetic evidence of multiple transmission of HIV-1 type 1 subtype F within Romania from adult blood donors to children. AIDS Res Hum Retroviruses 16 (2000) 327-336
10. Paraschiv S., Otelea D., Dinu M., Maxim D., and Tinischi M. Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains. Int J Infect Dis 11 (2007) 123-128
11. Wainberg M.A., Brenner B.G., and Turner D. Changing patterns in the selection of viral mutations among patients receiving nucleoside and nucleotide drug combinations directed against human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 49 (2005) 1671-1678
12. Van Vaerenbergh K., Laethem K.V., Albert J., Boucher C.A., Clotet B., Floridia M., et al. Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. Antimicrob Agents Chemother 44 (2000) 2109-2117
13. Gonzales M.J., Wu T.D., Taylor J., Belitskaya I., Kantor R., Israelski D., et al. Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors. AIDS 17 (2003) 791-799
14. Parikh M.U., Bacheler L., Koontz D., and Mellors J.V. The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations. J Virol 80 (2006) 4971-4977
15. Turner D., Brenner B., and Wainberg M.A. Relationships among various nucleoside resistance-conferring mutations in the reverse transcriptase of HIV-1. J Antimicrob Ther 53 (2004) 53-57
16. Masquelier B., Race E., Tamalet C., Descamps D., Izopet J., Buffet-Janvresse C., et al. Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors. Antimicrob Agents Chemother 45 (2001) 1836-1842
17. Lander B.A., Bloor S., Kemp D., Hertogs K., Desmet R.L., Miller V., et al. A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. Antimicrob Agents Chemother 43 (1999) 1961-1967
18. Yahi N., Tamalet C., Tourres C., Tivoli N., Ariasi F., Volot F., et al. Mutation patterns of reverse transcriptase and protease genes in human immunodeficiency virus type 1 infected patients undergoing combination therapy: survey of 787 sequences. J Clin Microbiol 37 (1999) 4099-4106
19. Cheung P.K., Wynhoven B., and Harrigan P.R. Which HIV-1 drug resistance mutations are common in clinical practice. AIDS Rev 6 (2004) 107-116